Invention Grant
- Patent Title: Implantable pharmaceutical composition prepared from components consisting of calcium sulfate alpha-hemihydrate, vancomycin and gentamicin
-
Application No.: US17842689Application Date: 2022-06-16
-
Publication No.: US12133862B2Publication Date: 2024-11-05
- Inventor: Sean Sydney Aiken , Phillip Anthony Laycock , John Joseph Cooper , John Stephen Bratt , Michael Christopher James Harris
- Applicant: Biocomposites Limited
- Applicant Address: GB Staffordshire
- Assignee: Biocomposites Limited
- Current Assignee: Biocomposites Limited
- Current Assignee Address: GB Staffordshire
- Agency: DAY PITNEY LLP
- Agent George N. Chaclas; Anthony A. Kassas
- Priority: GB2108727 20210618
- Main IPC: A61K33/06
- IPC: A61K33/06 ; A61K9/16 ; A61K31/7036 ; A61K38/14
Abstract:
The present disclosure concerns a composition for an implantable pharmaceutical composition prepared from components consisting only of calcium sulfate α-hemihydrate in combination with two antibiotics, vancomycin and gentamicin, for the treatment of infection in bone and soft tissue.
Public/Granted literature
Information query
